Lifordi Immunotherapeutics, Inc.

This is a very early study to check the safety and basic effects of a new drug called LFD-200, given as a weekly injection. It will first test single and multiple doses in healthy volunteers, then test multiple weekly doses in people with moderate to severe rheumatoid arthritis. …